Results 81 to 90 of about 2,349 (173)

Semiconducting Quasi One‐Dimensional (PbBr2)[Pb2P14]2, a Lead Bromide Adduct and Violet Phosphorus Derivative

open access: yesZeitschrift für anorganische und allgemeine Chemie, Volume 652, Issue 6, 07 April 2026.
The quasi‐one‐dimensional semiconductor Pb5Br2P28 was examined in terms of its structural and electronic properties. Single‐crystal X‐ray diffraction (SC‐XRD) and Raman spectroscopy support its description as neutral [Pb2P14] and [PbBr2] units. Combined with its semiconducting properties and high flexibility, Pb5Br2P28 emerges as a promising candidate ...
Kathrin Vosseler   +2 more
wiley   +1 more source

Thermally Activated Delayed Fluorescence in Phase‐Separated Nanostructures

open access: yesAdvanced Functional Materials, Volume 36, Issue 31, 16 April 2026.
A supramolecular, phase‐separation driven strategy yields charge transfer (CT) complexes from alternating electron‐deficient pyromellitic diimide and electron‐rich 4,5‐dibromoveratrole. The resulting CT complexes self‐assemble into lamellar nanosheets with nanometer‐sized domains that exhibit thermally activated delayed fluorescence (TADF) at room ...
Bart W.L. van den Bersselaar   +8 more
wiley   +1 more source

Improving Nefiracetam Dissolution and Solubility Behavior Using a Cocrystallization Approach

open access: yesPharmaceutics, 2020
In this work, we are the first to identify thirteen cocrystals of Nefiracetam, a poor water-soluble nootropic compound. Three of which were obtained with the biocompatible cocrystallization agents citric acid, oxalic acid, and zinc chloride. These latter
Xavier Buol   +6 more
doaj   +1 more source

Efficient Screening of Pharmaceutical Cocrystals by Microspacing In-Air Sublimation

open access: yes
Cocrystal screening and single-crystal growth remain the primary obstacles in the development of pharmaceutical cocrystals. Here, we present a new approach for cocrystal screening, microspacing in-air sublimation (MAS), to obtain new cocrystals and grow ...
Shuhong Song (9604140)   +10 more
core   +4 more sources

Acemetacin cocrystal structures by powder X-ray diffraction

open access: yesIUCrJ, 2017
Cocrystals of acemetacin drug (ACM) with nicotinamide (NAM), p-aminobenzoic acid (PABA), valerolactam (VLM) and 2-pyridone (2HP) were prepared by melt crystallization and their X-ray crystal structures determined by high-resolution powder X-ray ...
Geetha Bolla   +2 more
doaj   +1 more source

Design, synthesis and properties of pharmaceutical cocrystals

open access: yes, 2022
Cocrystals are “solids that are single phase crystalline materials made up of two or more  different molecular and/or ionic compounds generally in a stoichiometric ratio which are  neither solvates nor simple salts.” A primary reason for current interest
Molly M. Haskins (12586276)
core   +1 more source

Recent Advances in Pharmaceutical Cocrystals: From Bench to Market. [PDF]

open access: yesFront Pharmacol, 2021
Kumar Bandaru R   +6 more
europepmc   +1 more source

Solubility Advantage of Pharmaceutical Cocrystals

open access: yes, 2016
Pharmaceutical cocrystals can improve solubility, dissolution, and bioavailability of poorly water soluble drugs. However, true cocrystal solubility is not readily measured for highly soluble cocrystals because they can transform to the most stable drug ...
David J. Good (1469488)   +1 more
core   +1 more source

Vibrational Spectroscopy for Cocrystals Screening. A Comparative Study

open access: yesMolecules, 2018
A recurrent problem faced by the pharmaceutical industry when formulating drug products concerns poorly soluble drugs, which, despite having desirable pharmacological activity, present limited bioavailability.
Marisa Rodrigues   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy